Quince Therapeutics Inc Share Price Today: Live Updates & Key Insights
Quince Therapeutics Inc share price today is $0.086, up -8.78%. The stock opened at $0.0876 against the previous close of $0.0877, with an intraday high of $0.0948 and low of $0.0845.
Quince Therapeutics Inc Share Price Chart
Quince Therapeutics Inc
Quince Therapeutics Inc Share Price Performance
Quince Therapeutics Inc Institutional Holdings
Quince Therapeutics Inc Market Status
Quince Therapeutics Inc Fundamentals
Market Cap 4.45 M
PB Ratio 4.6112
PE Ratio 0.0
Enterprise Value -3.41 M
Total Assets 114.48 M
Volume 14002668
Quince Therapeutics Inc Company Financials
About Quince Therapeutics Inc & investment objective
Company Information Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Organisation Biotechnology
Employees 36
Industry Biotechnology
CEO Dr. Dirk Thye M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Quince Therapeutics Inc FAQs
What is the share price of Quince Therapeutics Inc today?
The current share price of Quince Therapeutics Inc is $0.086.
Can I buy Quince Therapeutics Inc shares in India?
Yes, Indian investors can buy Quince Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Quince Therapeutics Inc shares in India?
You can easily invest in Quince Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Quince Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Quince Therapeutics Inc.
Can I buy fractional shares of Quince Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Quince Therapeutics Inc?
Quince Therapeutics Inc has a market cap of $4.45 M.
In which sector does Quince Therapeutics Inc belong?
Quince Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Quince Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Quince Therapeutics Inc?
The PE ratio of Quince Therapeutics Inc is N/A and the PB ratio is 4.61.